Feds fine Lumosity developer over brain benefit claim
The company behind a popular "brain training" app will pay $2 million to settle federal allegations of deceiving customers. Lumosity suggested its games could delay conditions like dementia and Alzheimer’s disease without offering scientific proof. CBS News business analyst Jill Schlesinger joins “CBS This Morning" to discuss the Federal Trade Commission's crackdown and the implications for other companies.